Ruxandra Draghia-Akli

EVP, Research & Development · 2 filings · Latest: Mar 2, 2026

NOVAVAX INC

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
NVAX	Ruxandra Draghia Akli	—	May 7, 2026	Proposed Sale	$9.87	30,000	$296.1K	—	May 7 9:03 PM
NVAX	Ruxandra Draghia-Akli	EVP, Research & Development	Mar 3, 2026	Option Exercise	$0.00	26,667	—	34,876	Mar 5 11:00 AM